Skip to main content
Top
Published in: BMC Neurology 1/2012

Open Access 01-12-2012 | Research article

Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis

Authors: Robert W Motl, Yoojin Suh, Swathi Balantrapu, Brian M Sandroff, Jacob J Sosnoff, John Pula, Myla D Goldman, Bo Fernhall

Published in: BMC Neurology | Issue 1/2012

Login to get access

Abstract

Background

Researchers have recently advocated for the 2-minute walk (2MW) as an alternative for the 6-minute walk (6MW) to assess long distance ambulation in persons with multiple sclerosis (MS). This recommendation has not been based on physiological considerations such as the rate of oxygen consumption (V·O2) over the 6MW range.

Objective

This study examined the pattern of change in V·O2 over the range of the 6MW in a large sample of persons with MS who varied as a function of disability status.

Method

Ninety-five persons with clinically-definite MS underwent a neurological examination for generating an Expanded Disability Status Scale (EDSS) score, and then completion of the 6MW protocol while wearing a portable metabolic unit and an accelerometer.

Results

There was a time main effect on V·O2 during the 6MW (p = .0001) such that V·O2 increased significantly every 30 seconds over the first 3 minutes of the 6MW, and then remained stable over the second 3 minutes of the 6MW. This occurred despite no change in cadence across the 6MW (p = .84).

Conclusions

The pattern of change in V·O2 indicates that there are different metabolic systems providing energy for ambulation during the 6MW in MS subjects and steady state aerobic metabolism is reached during the last 3 minutes of the 6MW. By extension, the first 3 minutes would represent a test of mixed aerobic and anaerobic work, whereas the second 3 minutes would represent a test of aerobic work during walking.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pearson OR, Busse ME, van Deursen RW, Wiles CM: Quantification of walking mobility in neurological disorders. QJM. 2004, 97: 463-475.CrossRefPubMed Pearson OR, Busse ME, van Deursen RW, Wiles CM: Quantification of walking mobility in neurological disorders. QJM. 2004, 97: 463-475.CrossRefPubMed
2.
go back to reference Goldman MD, Motl RW, Rudick RA: Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord. 2010, 3: 229-239. 10.1177/1756285610374117.CrossRefPubMedPubMedCentral Goldman MD, Motl RW, Rudick RA: Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord. 2010, 3: 229-239. 10.1177/1756285610374117.CrossRefPubMedPubMedCentral
3.
go back to reference Larocca NG: Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient. 2011, 4: 189-201. 10.2165/11591150-000000000-00000.CrossRefPubMed Larocca NG: Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient. 2011, 4: 189-201. 10.2165/11591150-000000000-00000.CrossRefPubMed
4.
go back to reference Van Asch P: Impact of mobility impairment in multiple sclerosis 2-patients' perspectives. Eur Neurol Rev. 2011, 6: 115-120.CrossRef Van Asch P: Impact of mobility impairment in multiple sclerosis 2-patients' perspectives. Eur Neurol Rev. 2011, 6: 115-120.CrossRef
5.
go back to reference Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM: Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J. 1982, 284: 1607-1608. 10.1136/bmj.284.6329.1607.CrossRef Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM: Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J. 1982, 284: 1607-1608. 10.1136/bmj.284.6329.1607.CrossRef
6.
go back to reference Goldman MD, Marrie RA, Cohen JA: Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008, 14: 383-390. 10.1177/1352458507082607.CrossRefPubMed Goldman MD, Marrie RA, Cohen JA: Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008, 14: 383-390. 10.1177/1352458507082607.CrossRefPubMed
7.
go back to reference Motl RW, Weikert M, Suh Y, Sosnoff JJ, Pula J, Soaz C, Schimpl M, Lederer C, Daumer M: Accuracy of the actibelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis. Gait Posture. Motl RW, Weikert M, Suh Y, Sosnoff JJ, Pula J, Soaz C, Schimpl M, Lederer C, Daumer M: Accuracy of the actibelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis. Gait Posture.
8.
go back to reference Heffernan KS, Ranadive S, Weikert M, Lane A, Yan H, Fernhall B, Motl RW: Pulse pressure is associated with walking impairment in multiple sclerosis. J Neurol Sci. 2011, 309: 105-109. 10.1016/j.jns.2011.07.004.CrossRefPubMed Heffernan KS, Ranadive S, Weikert M, Lane A, Yan H, Fernhall B, Motl RW: Pulse pressure is associated with walking impairment in multiple sclerosis. J Neurol Sci. 2011, 309: 105-109. 10.1016/j.jns.2011.07.004.CrossRefPubMed
9.
go back to reference Gijbels D, Alders G, Van Hoof E, Charlier C, Roelants M, Broekmans T, et al: Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler. 2010, 16: 618-626. 10.1177/1352458510361357.CrossRefPubMed Gijbels D, Alders G, Van Hoof E, Charlier C, Roelants M, Broekmans T, et al: Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler. 2010, 16: 618-626. 10.1177/1352458510361357.CrossRefPubMed
10.
go back to reference Gijbels D, Eijnde B, Feys P: Comparison of the 2- and 6-minute walk test in multiple sclerosis. Mult Scler. Gijbels D, Eijnde B, Feys P: Comparison of the 2- and 6-minute walk test in multiple sclerosis. Mult Scler.
11.
go back to reference Astrand PO, Rodahl K: Textbook of Work Physiology. 1977, New York: McGraw-Hill Book Co Astrand PO, Rodahl K: Textbook of Work Physiology. 1977, New York: McGraw-Hill Book Co
12.
go back to reference Mathews DK, Stacy RW, Hoover GN: Physiology of muscular activity and exercise. 1964, New York: Ronald Press Mathews DK, Stacy RW, Hoover GN: Physiology of muscular activity and exercise. 1964, New York: Ronald Press
13.
go back to reference Motl RW, Dlugonski D, Weikert M, Agiovlasitis S, Fernhall B, Goldman M: Multiple sclerosis walking scale-12 and oxygen cost of walking. Gait Posture. 2010, 31: 506-510. 10.1016/j.gaitpost.2010.02.011.CrossRefPubMed Motl RW, Dlugonski D, Weikert M, Agiovlasitis S, Fernhall B, Goldman M: Multiple sclerosis walking scale-12 and oxygen cost of walking. Gait Posture. 2010, 31: 506-510. 10.1016/j.gaitpost.2010.02.011.CrossRefPubMed
14.
go back to reference Motl RW, Suh Y, Dlugonski D, Weikert M, Agiovlasitis S, Fernhall B, Goldman M: Oxygen cost of treadmill and over-ground walking in mildly disabled persons with multiple sclerosis. Neurol Sci. 2011, 32: 255-262.CrossRefPubMed Motl RW, Suh Y, Dlugonski D, Weikert M, Agiovlasitis S, Fernhall B, Goldman M: Oxygen cost of treadmill and over-ground walking in mildly disabled persons with multiple sclerosis. Neurol Sci. 2011, 32: 255-262.CrossRefPubMed
15.
go back to reference Savci S, Inal-Ince D, Arikan H, Guclu-Gunduz A, Cetisli-Korkmaz N, Armutlu K, Karabudak R: Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil. 2005, 27: 1365-1371. 10.1080/09638280500164479.CrossRefPubMed Savci S, Inal-Ince D, Arikan H, Guclu-Gunduz A, Cetisli-Korkmaz N, Armutlu K, Karabudak R: Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil. 2005, 27: 1365-1371. 10.1080/09638280500164479.CrossRefPubMed
16.
go back to reference Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983, 33: 1444-1452.CrossRefPubMed Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983, 33: 1444-1452.CrossRefPubMed
17.
go back to reference Motl RW, Snook EM, Agiovlasitis S: Does an accelerometer accurately measure steps taken under controlled conditions in adults with mild multiple sclerosis?. Disabil Health J. 2011, 4: 52-57. 10.1016/j.dhjo.2010.02.003.CrossRefPubMed Motl RW, Snook EM, Agiovlasitis S: Does an accelerometer accurately measure steps taken under controlled conditions in adults with mild multiple sclerosis?. Disabil Health J. 2011, 4: 52-57. 10.1016/j.dhjo.2010.02.003.CrossRefPubMed
18.
go back to reference Cohen J: Statistical Power Analysis for the Behavioral Sciences. 1988, New York: Academic, 3 Cohen J: Statistical Power Analysis for the Behavioral Sciences. 1988, New York: Academic, 3
19.
go back to reference Confavreux C, Vukusic S: Age at disability milestones in multiple sclerosis. Brain. 2006, 129: 595-605. 10.1093/brain/awh714.CrossRefPubMed Confavreux C, Vukusic S: Age at disability milestones in multiple sclerosis. Brain. 2006, 129: 595-605. 10.1093/brain/awh714.CrossRefPubMed
20.
go back to reference Canning CG, Ada L, Johnson JJ, McWhirter S: Walking capacity in mild to moderate Parkinson's disease. Arch Phys Med Rehabil. 2006, 87: 371-375. 10.1016/j.apmr.2005.11.021.CrossRefPubMed Canning CG, Ada L, Johnson JJ, McWhirter S: Walking capacity in mild to moderate Parkinson's disease. Arch Phys Med Rehabil. 2006, 87: 371-375. 10.1016/j.apmr.2005.11.021.CrossRefPubMed
21.
go back to reference Garber C, Friedman J: Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology. 2003, 60: 1119-1124.CrossRefPubMed Garber C, Friedman J: Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology. 2003, 60: 1119-1124.CrossRefPubMed
Metadata
Title
Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis
Authors
Robert W Motl
Yoojin Suh
Swathi Balantrapu
Brian M Sandroff
Jacob J Sosnoff
John Pula
Myla D Goldman
Bo Fernhall
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2012
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-12-6

Other articles of this Issue 1/2012

BMC Neurology 1/2012 Go to the issue